individual results vary based on physiology, lifestyle, diet, activity level, and the specific botanical formula
The findings show remarkable growth in rigor, scope, and collaborationbut also reveal persistent gaps that must be addressed if evidence-based addiction treatments are to reach everyone who needs them
Julian CG, Subudhi AW, Hill RC, Wilson MJ, Dimmen AC, Hansen KC, Roach RC
Access and Scale Access and Scale Existing widespread use of GLP-1s by physicians across medical contexts creates an opportunity to reach the scale that will be required to substantially impact society-wide addiction rates
Because it strongly affects glucose regulation, combining it with certain drugs, foods, or supplements can raise the risk of hypoglycemia or worsen side effects
(See here for more information on interaction with Part D plan drug coverage.) CMS has posted Frequently Asked Questions (FAQs) on the Bridge Model website and on separate web pages dedicated to beneficiaries, providers, pharmacies, and Part D plans